<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cheng H</submitter><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><pagination>113368</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8321683</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>190</volume><pubmed_abstract>D-2-hydroxyglutarate (D2HG) is over-produced as an oncometabolite due to mutations in isocitrate dehydrogenases (IDHs). Accumulation of D2HG can cause the dysfunction of many enzymes and genome-wide epigenetic alterations, which can promote oncogenesis. Quantification of D2HG at single-cell resolution can help understand the phenotypic signatures of IDH-mutant cancers and identify effective therapeutics. In this study, we developed an analytical method to detect D2HG levels in single cancer cells by adapting cascade enzymatic reactions on a resazurin-based fluorescence reporter. The resazurin probe was immobilized to the sensing surface via biotin-streptavidin interaction. This surface chemistry was rationally optimized to translate the D2HG levels to sensitive fluorescence readouts effici</pubmed_abstract><journal>Biosensors &amp; bioelectronics</journal><pubmed_title>Single-cell profiling of D-2-hydroxyglutarate using surface-immobilized resazurin analogs.</pubmed_title><pmcid>PMC8321683</pmcid><funding_grant_id>U01 CA217655</funding_grant_id><funding_grant_id>R03 CA227352</funding_grant_id><funding_grant_id>U54 CA199090</funding_grant_id><pubmed_authors>Li Z</pubmed_authors><pubmed_authors>Guo Z</pubmed_authors><pubmed_authors>Mo L</pubmed_authors><pubmed_authors>Wei W</pubmed_authors><pubmed_authors>Xue M</pubmed_authors><pubmed_authors>Cheng H</pubmed_authors><pubmed_authors>Shao S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Single-cell profiling of D-2-hydroxyglutarate using surface-immobilized resazurin analogs.</name><description>D-2-hydroxyglutarate (D2HG) is over-produced as an oncometabolite due to mutations in isocitrate dehydrogenases (IDHs). Accumulation of D2HG can cause the dysfunction of many enzymes and genome-wide epigenetic alterations, which can promote oncogenesis. Quantification of D2HG at single-cell resolution can help understand the phenotypic signatures of IDH-mutant cancers and identify effective therapeutics. In this study, we developed an analytical method to detect D2HG levels in single cancer cells by adapting cascade enzymatic reactions on a resazurin-based fluorescence reporter. The resazurin probe was immobilized to the sensing surface via biotin-streptavidin interaction. This surface chemistry was rationally optimized to translate the D2HG levels to sensitive fluorescence readouts effici</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Oct</publication><modification>2025-04-05T20:11:54.636Z</modification><creation>2025-04-05T20:11:54.636Z</creation></dates><accession>S-EPMC8321683</accession><cross_references><pubmed>34098361</pubmed><doi>10.1016/j.bios.2021.113368</doi></cross_references></HashMap>